PulseAugur
EN
LIVE 07:05:23

Universal Brain secures FDA clearance for EEG-based psychiatric assessment tool

By PulseAugur Editorial · [1 sources] ·

Universal Brain has received FDA 510(k) clearance for its Neurotique™ platform, a device designed to assess cognitive and emotional brain function for psychiatric diagnosis and treatment. The platform utilizes a dry EEG baseball cap with EOG electrodes and an integrated digital testing system to measure brain activity via event-related potentials. Founded in 2022, Universal Brain has secured $7.9 million in seed funding and a $2 million grant from the Japanese government, with plans to launch clinically this summer and pursue pharma contracts. AI

IMPACT This FDA clearance for a neurotech device could accelerate the integration of AI-driven diagnostics in mental healthcare, potentially improving treatment accuracy and patient outcomes.

RANK_REASON FDA clearance for a neurotech device for psychiatric assessment.

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Universal Brain secures FDA clearance for EEG-based psychiatric assessment tool

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Tool
FDA clearance for a neurotech device for psychiatric assessment.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
product, infra
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
High
Clearly on-topic for AI-industry coverage.
Story freshness
56 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Naveen Rao, Contributor ·

    Psychiatry Lacks Biomarkers. Can This EEG Ballcap Get A Base Hit?

    Universal Brain's EEG cap seeks to bring precision into mental health treatment and drug development. With $7.9 million raised, they are entering a fast-moving landscape.

RELATED ENTITIES

RELATED TOPICS